Eden Spine gained FDA 510(k) clearance to market the SPHYNX™ titanium plate to treat thoracolumbar instabilities. SPHYNX complements GIZA™, an expandable titanium vertebral body replacement with rotatable endplates.
SPHYNX is implanted in an anterolateral approach. The device was granted CE Mark approval in 2016.
Eden Spine gained FDA 510(k) clearance to market the SPHYNX™ titanium plate to treat thoracolumbar instabilities. SPHYNX complements GIZA™, an expandable titanium vertebral body replacement with rotatable endplates.
SPHYNX is implanted in an anterolateral approach. The device was...
Eden Spine gained FDA 510(k) clearance to market the SPHYNX™ titanium plate to treat thoracolumbar instabilities. SPHYNX complements GIZA™, an expandable titanium vertebral body replacement with rotatable endplates.
SPHYNX is implanted in an anterolateral approach. The device was granted CE Mark approval in 2016.
Copy to clipboard 
